We provide 1 form of Infigratinib
Infigratinib
872511-34-7
|
559.187
|
5.788
Infigratinib is an FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement.
BGJ398 | NVP-BGJ398 | infigratinib
Infigratinib is an FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement.
BGJ398 | NVP-BGJ398 | infigratinib
$55/5 mg
(EBC)
1
We provide 0 compound for Infigratinib